Sonia T. Oskouei, PharmD, emphasized strategies to streamline regulations and evolve to overcome barriers and expand the ...

Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to ...

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

The action directs the Food and Drug Administration to facilitate approval of state importation programs and to streamline the approval for lower-cost generics and biosimilars. So far, only one state, ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has received U.S. Food and Drug Administration (U.S. FDA) approval for its Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous ...

Per reports, India supplies over 45 per cent of generic and 15 per cent of biosimilar drugs used in the US. Firms like Dr Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma and Gland Pharma ...

Biosimilars Council’s Craig Burton predicted that only 10% of the drugs coming off patent soon will have competition. Craig Burton, executive director of the Biosimilars Council, testified ...

April 8 (Reuters) - President Donald Trump on Tuesday said he told the Taiwan Semiconductor Manufacturing Company, which has pledged to build new factories in the United States, it would pay a tax ...

Teva and Samsung Bioepis have launched Epysqli, a cost-saving Soliris biosimilar, offering a 30% discount and new hope for patients with rare, life-threatening hematologic conditions. Teva ...

Tresiba’s strong profile in the long-acting insulin market hasn’t been enough to defend it from US pricing pressure due to competition from Sanofi and Lilly, and biosimilar insulins have ...